Kuros Biosciences Reports First Half of 2025 Results
(SWX:KURN), Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences Reports First Half of 2025 Results Financial Highlights Total Medical Device sales rose by 78% to USD 63.5 million in H1 2025 (H1 2024: USD 35.7 million) Direct MagnetOs(TM) sales increased by 77% to USD 62.7 million in H1 2025 (H1 […]